Innate Pharma plans Phase 3 lacutamab trial, names new CMO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Biophan Technologies, Inc. (AMEX: IPH) | Delayed: 0.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $0.04 | |||
| Open | $0.04 | 52 Week Low | $0.04 | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $0.00 | |||
| Volume | 71,303 | |||||
| (NASDAQ: IPHA) | Delayed: 1.50 -0.07 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.57 | 52 Week High | $ | |||
| Open | $1.51 | 52 Week Low | $ | |||
| Day High | $1.53 | P/E | N/A | |||
| Day Low | $1.41 | EPS | $ | |||
| Volume | 32,715 | |||||
